CorMedix Inc.

CRMDNASDAQ • USD
7.28 USD
↗ 0.02 (0.28%)AT CLOSE (03:59 PM EDT)
7.28
↘ 0.00 (0.07%)
POST MARKET (AS OF 05:53 PM EDT)
Post Market
AS OF 05:53 PM EDT
7.28
↘ 0.00 (0.07%)
🟢Market: OPEN

CorMedix Inc. (CRMD) trades at $7.28 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a weak Piotroski F-Score of 1/9, exceptional Return on Equity (40.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CRMD appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 6, 2026.

Open?$7.38
High?$7.40
Low?$7.13
Prev. Close?$7.26
Volume?744.3K
Avg. Volume?897.1K
VWAP?$7.22
Rel. Volume?0.83x
Bid / Ask
Bid?$6.23 × 100
Ask?$8.32 × 100
Spread?$2.09
Midpoint?$7.28
Valuation & Ratios
Market Cap?565.9M
Shares Out?77.9M
Float?70.5M
Float %?90.4%
P/E Ratio?3.02
P/B Ratio?1.23
EPS?$2.40
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Employees
191
Market Cap
565.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2010-05-13
Address
389 INTERPACE PKWY, SUITE 450
PARSIPPANY, NJ 07054
Phone: 908-517-9500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
46
Momentum?
23
Short Sent.?
19
Piotroski F-Score?1/9Weak
Altman Z-Score?2.28Grey
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?22.99%Squeeze Risk
Short Interest?16.2M
Days to Cover?18.5
Free Float70.5M
Avg Daily Volume876.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.56Strong
Quick Ratio?2.36Strong
Cash Ratio?1.37Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
3.0CHEAP▾
P/B?
Peers
100
S&P
93
1.23CHEAP▾
P/S?
Peers
100
S&P
83
1.22CHEAP▾
P/FCF?
Peers
100
S&P
97
2.3CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
1.2CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.67CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
88
40.6%STRONG▾
ROA?
Peers
50
S&P
97
20.7%STRONG▾
Cash Flow & Enterprise
FCF?$250.4M
Enterprise Value?$309.2M
Fundamentals ratios updated end of day